PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
05-Sep-2022 Global Folding Boxboard Market to 2027 - by Type, Material, Application and Region - ResearchAndMarkets.com Businesswire
05-Sep-2022 IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Patients with Advanced Biliary Tract Cancer Businesswire
05-Sep-2022 Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2022 Businesswire
05-Sep-2022 Biosimilars Global Market Opportunities and Strategies Report 2022: Long-term Forecast to 2026 & 2031 - ResearchAndMarkets.com Businesswire
05-Sep-2022 Single-use Bioprocessing Market Research - Global Opportunity Analysis and Industry Forecasts, 2020-2021 & 2022-2030 - ResearchAndMarkets.com Businesswire
05-Sep-2022 Software And BPO Services Global Market Report 2022: Emergence of Startups as Major Clients of Software and BPO Service Providers Driving Growth - ResearchAndMarkets.com Businesswire
05-Sep-2022 REPLY: Roboverse Reply Wins AIRA Challenge 2022 with Spot® from Boston Dynamics Businesswire
05-Sep-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
05-Sep-2022 OSE Immunotherapeutics to Present New Data on Tedopi® from Phase 3 Clinical Trial in Patients with Advanced Non-Small Cell Lung Cancer after Failure to Immune Checkpoint Inhibitors at ESMO Congress 2022 Businesswire
05-Sep-2022 Wugen Announces Presentation of WU-NK-101 Preclinical Data at the European Society for Medical Oncology (ESMO) Congress 2022 Businesswire
03-Sep-2022 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Sep-2022 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Businesswire
02-Sep-2022 NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing Businesswire
02-Sep-2022 Kessler Topaz Meltzer & Check, LLP: Bayer Corporation to Pay $40 Million to Settle Whistleblower Claims Alleging Fraud in Marketing Three Drugs Businesswire
02-Sep-2022 CVD Equipment Corporation Appoints Richard Catalano as Chief Financial Officer Businesswire
02-Sep-2022 Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months Businesswire
02-Sep-2022 Oak Hill Bio to Participate in Citi 17th Annual BioPharma Conference Businesswire
02-Sep-2022 Adam G. Kelly, Esquire, to Receive the 2022 American Inns of Court Professionalism Award for the Federal Circuit Businesswire
02-Sep-2022 IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022 Businesswire
02-Sep-2022 NCBiotech-Led Coalition Wins Phase 2 Build Back Better Regional Challenge Award Businesswire